Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
Suppl 2
|
pubmed:dateCreated |
1982-3-26
|
pubmed:abstractText |
Ulcer healing and relapse rates after treatment with cimetidine and sucralfate in 112 subjects with endoscopically proven gastric and duodenal ulcers were compared in a randomized trial. Four grams of sucralfate were administered in four divided doses each day; 200 mg cimetidine was administered three times during the day with the fourth dose of 400 mg given at night. The subjects were divided into four treatment groups: (1) subjects with duodenal ulcers treated with sucralfate; (2) subjects with duodenal ulcers treated with cimetidine; (3) subjects with gastric ulcers treated with sucralfate; and (4) subjects with gastric ulcers treated with cimetidine. Endoscopy was repeated at 6 weeks after treatment was initiated; subjects with unhealed ulcers at 6 weeks were reendoscoped at 12 weeks. Eighty-three percent of duodenal ulcers in subjects treated with sucralfate healed at 6 weeks, the rest by week 12. Cimetidine-treated subjects with duodenal ulcer had healing rates of 71 and 86% at 6 and 12 weeks. Cimetidine-treated subjects with gastric ulcers showed healing rates of 75 and 89% at 6 and 12 weeks, respectively. In the gastric ulcer group, 63% of sucralfate-treated subjects were healed at 6 weeks, and 78% were healed by 12 weeks, respectively. Eighty-six of the subjects were followed for 1 year or until endoscopy showed relapse. Subjects treated with cimetidine on a short-term basis relapsed earlier than those were treated with sucralfate at 12 weeks, but at 1 year, the relapse rates were about 70% for both groups.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Aluminum,
http://linkedlifedata.com/resource/pubmed/chemical/Anti-Ulcer Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Cimetidine,
http://linkedlifedata.com/resource/pubmed/chemical/Guanidines,
http://linkedlifedata.com/resource/pubmed/chemical/Sucralfate
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0192-0790
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
3
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
163-5
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:7033353-Aluminum,
pubmed-meshheading:7033353-Anti-Ulcer Agents,
pubmed-meshheading:7033353-Cimetidine,
pubmed-meshheading:7033353-Clinical Trials as Topic,
pubmed-meshheading:7033353-Duodenal Ulcer,
pubmed-meshheading:7033353-Follow-Up Studies,
pubmed-meshheading:7033353-Guanidines,
pubmed-meshheading:7033353-Humans,
pubmed-meshheading:7033353-Random Allocation,
pubmed-meshheading:7033353-Recurrence,
pubmed-meshheading:7033353-Stomach Ulcer,
pubmed-meshheading:7033353-Sucralfate,
pubmed-meshheading:7033353-Time Factors
|
pubmed:year |
1981
|
pubmed:articleTitle |
Ulcer healing and relapse rates after initial treatment with cimetidine or sucralfate.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial
|